Since Thr212 is a direct target of kinase GSK3β [84], and the activity of GSK3β increase during aging, and AD pathology [84–86], the increased nuclear phosphorylated Tau with aging may be attributed to the increase of GSK3β [6]. Here, MAPT is linked to Alzheimer disease.